Recent genome-wide association studies (GWAS) and hypothesis driven candidate gene approaches had determined that the FOXE1 genetic variant is downstream of the TSH-cAMP pathway, and is a suspected risk factor for follicular-cell-derived thyroid cancer [24]. Here, FOXE1 is linked to thyroid gland carcinoma.